Systematic review compares oncological and perioperative outcomes of robotic-assisted and laparoscopic surgery in colorectal cancer, indicating RAS may have advantages.
Minimally invasive approaches such as laparoscopic surgery (LS) and robotic‐assisted surgery (RAS) have transformed colorectal cancer (CRC) management. This systematic review and meta‐analysis evaluated nine randomized controlled trials encompassing 2,758 patients to compare RAS and LS regarding perioperative, oncological, and long‐term outcomes. RAS showed longer operative time but yielded benefits such as reduced conversion rates, greater lymph node retrieval, and lower circumferential resection margin (CRM) positivity. Both techniques demonstrated comparable safety, mortality, and overall complication rates. While RAS presents certain advantages, further research is required to determine its cost‐effectiveness and long‐term oncological impact. Trial Registration: PROSPERO CRD420251025102.
No takes yet. Share an insight, caveat, or question.
Filho et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: